Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ... The Lancet Psychiatry 7 (10), 875-882, 2020 | 1560 | 2020 |
Multi-system neurological disease is common in patients with OPA1 mutations P Yu-Wai-Man, PG Griffiths, GS Gorman, CM Lourenco, AF Wright, ... Brain 133 (3), 771-786, 2010 | 451 | 2010 |
A proposal for new diagnostic criteria for ALS JM Shefner, A Al-Chalabi, MR Baker, LY Cui, M de Carvalho, A Eisen, ... Clinical Neurophysiology 131 (8), 2020 | 394 | 2020 |
Contributions of descending and ascending pathways to corticomuscular coherence in humans CL Witham, CN Riddle, MR Baker, SN Baker The Journal of physiology 589 (15), 3789-3800, 2011 | 264 | 2011 |
Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease L Rochester, AJ Yarnall, MR Baker, RV David, S Lord, B Galna, DJ Burn Brain 135 (9), 2779-2788, 2012 | 244 | 2012 |
TDP-43 proteinopathies: a new wave of neurodegenerative diseases EMJ De Boer, VK Orie, T Williams, MR Baker, HM De Oliveira, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (1), 86-95, 2021 | 231 | 2021 |
The effect of diazepam on motor cortical oscillations and corticomuscular coherence studied in man MR Baker, SN Baker The Journal of physiology 546 (3), 931-942, 2003 | 218 | 2003 |
Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance G Pfeffer, GS Gorman, H Griffin, M Kurzawa-Akanbi, EL Blakely, I Wilson, ... Brain 137 (5), 1323-1336, 2014 | 175 | 2014 |
Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study STJ Ray, O Abdel-Mannan, M Sa, C Fuller, GK Wood, K Pysden, M Yoong, ... The Lancet Child & Adolescent Health 5 (9), 631-641, 2021 | 170 | 2021 |
Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease KM Fisher, B Zaaimi, TL Williams, SN Baker, MR Baker Brain 135 (9), 2849-2864, 2012 | 151 | 2012 |
Treatment of stiff person syndrome with rituximab MR Baker, M Das, J Isaacs, PRW Fawcett, D Bates Journal of Neurology, Neurosurgery & Psychiatry 76 (7), 999-1001, 2005 | 126 | 2005 |
Botulinum toxin: an update on pharmacology and newer products in development S Choudhury, MR Baker, S Chatterjee, H Kumar Toxins 13 (1), 58, 2021 | 101 | 2021 |
The relationship between enhanced reticulospinal outflow and upper limb function in chronic stroke patients S Choudhury, A Shobhana, R Singh, D Sen, SS Anand, S Shubham, ... Neurorehabilitation and neural repair 33 (5), 375-383, 2019 | 76 | 2019 |
Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease? AJ Yarnall, L Rochester, MR Baker, R David, TK Khoo, GW Duncan, ... Movement Disorders 28 (9), 1285-1288, 2013 | 72 | 2013 |
Stiff person syndrome ME Duddy, MR Baker Immune-Mediated Neuromuscular Diseases 26, 147-165, 2009 | 70 | 2009 |
Neurophysiological biomarkers for Lewy body dementias RA Cromarty, GJ Elder, S Graziadio, M Baker, L Bonanni, M Onofrj, ... Clinical Neurophysiology 127 (1), 349-359, 2016 | 66 | 2016 |
Muscle responses to transcranial stimulation in man depend on background oscillatory activity WK Mitchell, MR Baker, SN Baker The Journal of physiology 583 (2), 567-579, 2007 | 62 | 2007 |
Corticospinal activation confounds cerebellar effects of posterior fossa stimuli KM Fisher, HM Lai, MR Baker, SN Baker Clinical neurophysiology 120 (12), 2109-2113, 2009 | 61 | 2009 |
Electroencephalographic markers in dementia N Malek, MR Baker, C Mann, J Greene Acta Neurologica Scandinavica 135 (4), 388-393, 2017 | 59 | 2017 |
Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study AL Ross Russell, M Hardwick, A Jeyanantham, LM White, S Deb, ... Brain Communications 3 (3), fcab168, 2021 | 56 | 2021 |